Structure‐function analyses of the kit receptor for the steel factor

Binding of the Steel factor (SLF) to the product of the c‐kit proto‐oncogene stimulates the receptor's intrinsic tyrosine kinase that phosphorylates a set of cytoplasmic signaling molecules. Germ‐line mutations in the genes that encode the receptor or the ligand result in remarkably similar phenotypes that affect melanogenesis, erythropoiesis and gametogenesis in mice. We concentrated on the initial events of the signal transduction pathway that underlies these processes. The extracellular portion of Kit is comprised of five immunoglobulin‐(Ig)‐like domains. Ligand binding to this domain induces rapid and extensive dimerization of the receptor molecules in a mechanism that involves monovalent binding of the dimeric ligand, followed by an increase in receptors' affinity and gradual stabilization of the dimers. It thus appears that Kit has at least two functions: ligand binding and ligand‐induced receptor dimerization, in addition to the kinase activity. Both functions are independent of the transmembrane and cytoplasmic domains, as a recombinant soluble ectodomain retained high affinity to SLF and ligand‐dependent dimerization. In order to correlate these functions with specific structures, we employed ligand‐competitive monoclonal antibodies, soluble deletion mutants of the ectodomain and chimeric human‐mouse Kit proteins. These approaches indicated that the N‐terminal three Ig‐like domains constitute the binding site, whose core is the second domain. Further experiments suggested that a putative dimerization site is distinct from the binding cleft and may be located on the fourth Ig‐like domain.

[1]  S. Nishikawa,et al.  Interspecies molecular chimeras of kit help define the binding site of the stem cell factor , 1993, Molecular and cellular biology.

[2]  M. Brizzi,et al.  Soluble c-kit proteins and antireceptor monoclonal antibodies confine the binding site of the stem cell factor. , 1993, The Journal of biological chemistry.

[3]  M. Barbacid,et al.  Steel factor stimulates the tyrosine phosphorylation of the proto-oncogene product, p95vav, in human hemopoietic cells. , 1992, The Journal of biological chemistry.

[4]  Y Yarden,et al.  An oncogenic point mutation confers high affinity ligand binding to the neu receptor. Implications for the generation of site heterogeneity. , 1992, The Journal of biological chemistry.

[5]  S. Lev,et al.  Dimerization and activation of the kit receptor by monovalent and bivalent binding of the stem cell factor. , 1992, The Journal of biological chemistry.

[6]  S. Lev,et al.  A recombinant ectodomain of the receptor for the stem cell factor (SCF) retains ligand-induced receptor dimerization and antagonizes SCF-stimulated cellular responses. , 1992, Journal of Biological Chemistry.

[7]  C. Turck,et al.  Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways , 1992, Cell.

[8]  Y. Yarden,et al.  A confined variable region confers ligand specificity on fibroblast growth factor receptors: implications for the origin of the immunoglobulin fold. , 1992, The EMBO journal.

[9]  V. Duronio,et al.  p21ras activation via hemopoietin receptors and c-kit requires tyrosine kinase activity but not tyrosine phosphorylation of p21ras GTPase-activating protein. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[10]  S. Aaronson,et al.  A deletion in the extracellular domain of the alpha platelet-derived growth factor (PDGF) receptor differentially impairs PDGF-AA and PDGF-BB binding affinities. , 1992, The Journal of biological chemistry.

[11]  M. Roussel,et al.  Random mutagenesis of CSF‐1 receptor (FMS) reveals multiple sites for activating mutations within the extracellular domain. , 1992, The EMBO journal.

[12]  D. Williams,et al.  c-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas. , 1992, Molecular biology of the cell.

[13]  P. Besmer The kit ligand encoded at the murine Steel locus: a pleiotropic growth and differentiation factor , 1992, Current Biology.

[14]  M. Ultsch,et al.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. , 1992, Science.

[15]  S. Werner,et al.  Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities , 1992, Molecular and cellular biology.

[16]  C. Heldin,et al.  Activation of the human c‐kit product by ligand‐induced dimerization mediates circular actin reorganization and chemotaxis. , 1991, The EMBO journal.

[17]  H. Broxmeyer,et al.  The kit receptor and its ligand, steel factor, as regulators of hemopoiesis. , 1991, Cancer cells.

[18]  P. Besmer The kit ligand encoded at the murine Steel locus: a pleiotropic growth and differentiation factor. , 1991, Current opinion in cell biology.

[19]  A. Ullrich,et al.  Substrate phosphorylation specificity of the human c-kit receptor tyrosine kinase. , 1991, The Journal of biological chemistry.

[20]  A. Ullrich,et al.  Insulin and insulin-like growth factor-1 binding specificity is determined by distinct regions of their cognate receptors. , 1991, The Journal of biological chemistry.

[21]  Alastair,et al.  Signal transduction by normal isoforms and W mutant variants of the Kit receptor tyrosine kinase. , 1991, The EMBO journal.

[22]  Z. Kelman,et al.  Transmembrane signalling receptors for cytokines and growth factors , 1991 .

[23]  S. Nishikawa,et al.  In utero manipulation of coat color formation by a monoclonal anti‐c‐kit antibody: two distinct waves of c‐kit‐dependency during melanocyte development. , 1991, The EMBO journal.

[24]  T. Pawson,et al.  The Steel/W transduction pathway: kit autophosphorylation and its association with a unique subset of cytoplasmic signaling proteins is induced by the Steel factor , 1991, Molecular and cellular biology.

[25]  N. Møłler,et al.  The ligand specificities of the insulin receptor and the insulin-like growth factor I receptor reside in different regions of a common binding site. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[26]  P. Leder,et al.  Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the SId mutant , 1991, Cell.

[27]  S. Lev,et al.  A specific combination of substrates is involved in signal transduction by the kit‐encoded receptor. , 1991, The EMBO journal.

[28]  M. Pazin,et al.  A functional soluble extracellular region of the platelet-derived growth factor (PDGF) beta-receptor antagonizes PDGF-stimulated responses. , 1991, The Journal of biological chemistry.

[29]  C. Betzel,et al.  The secreted form of the epidermal growth factor receptor. Characterization and crystallization of the receptor-ligand complex. , 1990, The Journal of biological chemistry.

[30]  W. Rutter,et al.  The cysteine-rich domains of the insulin and insulin-like growth factor I receptors are primary determinants of hormone binding specificity. Evidence from receptor chimeras. , 1990, The Journal of biological chemistry.

[31]  D. Steiner,et al.  Baculovirus-directed expression of the human insulin receptor and an insulin-binding ectodomain. , 1990, The Journal of biological chemistry.

[32]  K. Siddle,et al.  Deletion analysis of the human insulin receptor ectodomain reveals independently folded soluble subdomains and insulin binding by a monomeric alpha-subunit. , 1990, The Journal of biological chemistry.

[33]  K. Nocka,et al.  The dominant W42 spotting phenotype results from a missense mutation in the c-kit receptor kinase. , 1990, Science.

[34]  J. Downing,et al.  Ligand and protein kinase C downmodulate the colony-stimulating factor 1 receptor by independent mechanisms , 1989, Molecular and cellular biology.

[35]  A. Basu,et al.  Inhibition of tyrosine kinase activity of the epidermal growth factor (EGF) receptor by a truncated receptor form that binds to EGF: role for interreceptor interaction in kinase regulation. , 1989, Molecular and cellular biology.

[36]  A. Ullrich,et al.  Functional analysis of the ligand binding site of EGF‐receptor utilizing chimeric chicken/human receptor molecules. , 1989, The EMBO journal.

[37]  D. Housman,et al.  The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene , 1988, Cell.

[38]  W. Rutter,et al.  Properties of the insulin receptor ectodomain. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[39]  V. Chapman,et al.  The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus , 1988, Nature.

[40]  J. Spiess,et al.  Production of an epidermal growth factor receptor-related protein. , 1984, Science.

[41]  T. Fleming,et al.  Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[42]  E. Russell Hereditary anemias of the mouse: a review for geneticists. , 1979, Advances in genetics.